VeriMomtetrahydro-methyl-methylpropyl)-pyran-4-ol hamilelikte güvenli mi?
No harmonised CLP classification (Annex VI) or SCCS/CIR safety assessment was found, and the RIFM/Food and Chemical Toxicology safety assessment (systematic review) concluded no reproductive/developmental hazard and an MOE >100 for developmental/reproductive endpoints. Manufacturer SDSs sometimes self-classify as Repr. Cat.2 (H361) but these appear to be supplier self-classifications rather than harmonised regulatory classifications, so they do not change the hazard default. Topical cosmetic use therefore has low but measurable exposure (adult e=1). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31199993/?utm_source=openai))
Related ingredients
Frequently asked questions
- tetrahydro-methyl-methylpropyl)-pyran-4-ol hamilelikte güvenli mi?
- No harmonised CLP classification (Annex VI) or SCCS/CIR safety assessment was found, and the RIFM/Food and Chemical Toxicology safety assessment (systematic review) concluded no reproductive/developmental hazard and an MOE >100 for developmental/reproductive endpoints. Manufacturer SDSs sometimes self-classify as Repr. Cat.2 (H361) but these appear to be supplier self-classifications rather than harmonised regulatory classifications, so they do not change the hazard default. Topical cosmetic use therefore has low but measurable exposure (adult e=1). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31199993/?utm_source=openai))
- tetrahydro-methyl-methylpropyl)-pyran-4-ol emzirirken güvenli mi?
- No data indicating specific lactation/transfer or breastmilk exposure were identified in authoritative reviews; the RIFM assessment did not identify reproductive/developmental effects. By default there is low but measurable systemic exposure from topical use so breastfeeding exposure is low but measurable. Supplier SDS self-classifications do not constitute harmonised evidence of reproductive hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31199993/?utm_source=openai))
- tetrahydro-methyl-methylpropyl)-pyran-4-ol bebek cildi için güvenli mi?
- No infant-specific toxicity studies or signals were found and the RIFM review found no developmental/reproductive hazard. Because infant skin has higher absorption surface-area-to-weight and the adult exposure is measurable, exposure is increased by one category for babies (adult e=1 → baby e=2). No evidence was found to increase hazard (h) or mechanism (m) for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/31199993/?utm_source=openai))
- VeriMom tetrahydro-methyl-methylpropyl)-pyran-4-ol nasıl puanlıyor?
- VeriMom tetrahydro-methyl-methylpropyl)-pyran-4-ol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tetrahydro-methyl-methylpropyl)-pyran-4-ol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.